Bayou Surgical

Coming – August 13

Solving A Billion Dollar Problem In Minimally Invasive Surgery

Date and Time

August 13

–

4:00 PM ET / 1:00 PM PT

Details will be shared with confirmed attendees

About this Event

NIH data shows surgeons lose clear visualization in 37% of laparoscopic procedures due to scope contamination, forcing costly and potentially dangerous mid-surgery interruptions.

Join us for an expert panel discussion on how physicians and MedTech executive are working to solve this problem, saving lives and millions of dollars in healthcare costs. Our expert panel includes:
  • Dr. Wayne Poll: Urologist, specialized in laparoscopic and robotic minimally invasive surgery. He founded and raised venture capital for Minimally Invasive Devices, Inc. (MID), and developed the FloShield product line
  • Sharad Joshi: CEO, Bayou Surgical, a veteran medical device entrepreneur, inventor, and executive who has spent more than three decades bringing innovative minimally invasive surgical technologies to market
In addition they will discuss troCarWash™, a lens cleaning platform that is redefining visualization in minimally invasive surgery. This is a $4.5B global market and is scaling its laparoscopic platform while preparing to launch a robotic program.

Register today to learn more about this persistent problem and the solutions being developed to solve it.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.